Bcr-Abl inhibition as a modality of CML therapeutics
- PMID: 11553417
- DOI: 10.1016/s0304-419x(01)00022-1
Bcr-Abl inhibition as a modality of CML therapeutics
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
